Cardiovascular Imaging with PET, CT, and MR Imaging

PET Clinics

Volumn 3, Issue 3, 2008, Pages 411-434

  Takalkar, Amol ^a,b   Chen, Wengen ^c   Desjardins, Benoit ^c   Alavi, Abass ^c   Torigian, Drew A ^c  

^a Biomedical Research Foundation of Northwest Louisiana   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiac CT; Cardiac MR; Cardiac PET; FDG; Myocardial viability

Indexed keywords

AMMONIA N 13; CHLORINE RB 82; FLUORODEOXYGLUCOSE F 18; NITROGEN 13; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART TUMOR; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 67449105358     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2009.03.004     Document Type: Review

References (158)

1. Bax J.J., Visser F.C., van Lingen A., et al. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Int J Cardiovasc Imaging 13 2 (1997) 145-155 discussion 57-60
2. Krivokapich J., Smith G.T., Huang S.C., et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80 5 (1989) 1328-1337
3. Hutchins G.D., Schwaiger M., Rosenspire K.C., et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15 5 (1990) 1032-1042
4. Choi Y., Huang S.C., Hawkins R.A., et al. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med 34 3 (1993) 488-497
5. Beanlands R.S., Muzik O., Melon P., et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 26 6 (1995) 1465-1475
6. Choi Y., Huang S.C., Hawkins R.A., et al. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med 40 6 (1999) 1045-1055
7. Schwaiger M., Ziegler S.I., and Bengel F.M. Assessment of myocardial blood flow with positron emission tomography. In: Pohost G.M., O'Rourke R.A., and Berman D.S. (Eds). Imaging in cardiovascular disease (2000), Lippincott Williams and Wilkins, Philadelphia 195-212
8. Bacharach S.L., Bax J.J., Case J., et al. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol 10 5 (2003) 543-556
9. Beller G.A., and Bergmann S.R. Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol 11 1 (2004) 71-86
10. Sampson U.K., Dorbala S., Limaye A., et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 49 10 (2007) 1052-1058
11. Go R.T., Marwick T.H., MacIntyre W.J., et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 31 12 (1990) 1899-1905
12. Stewart R.E., Schwaiger M., Molina E., et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 67 16 (1991) 1303-1310
13. Bateman T.M., Heller G.V., McGhie A.I., et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 13 1 (2006) 24-33
14. Nandalur K.R., Dwamena B.A., Choudhri A.F., et al. Diagnostic performance of positron emission tomography in the detection of coronary artery disease: a meta-analysis. Acad Radiol 15 4 (2008) 444-451
15. Patterson R.E., Eisner R.L., and Horowitz S.F. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 91 1 (1995) 54-65
16. Schoenhagen P., Halliburton S.S., Stillman A.E., et al. Noninvasive imaging of coronary arteries: current and future role of multi-detector row CT. Radiology 232 1 (2004) 7-17
17. Schoepf U.J., Becker C.R., Ohnesorge B.M., et al. CT of coronary artery disease. Radiology 232 1 (2004) 18-37
18. Leber A.W., Knez A., Becker A., et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol 43 7 (2004) 1241-1247
19. Di Carli M., Dorbala S., Limaye A., et al. Clinical value of hybrid PET/CT cardiac imaging: complementary roles of multi-detector CT coronary angiography and stress PET perfusion imaging. J Am Coll Cardiol 47 4 (2006) 115A
20. Klocke F.J., Baird M.G., Lorell B.H., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 42 7 (2003) 1318-1333
21. Budoff M.J. Computed Tomography. In: Budoff M.J., and Shinbane J.S. (Eds). Cardiac CT imaging: diagnosis of cardiovascular disease (2006), Springer-Verlag, London 1-18
22. Callister T.Q., Raggi P., Cooil B., et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339 27 (1998) 1972-1978
23. O'Rourke R.A., Brundage B.H., Froelicher V.F., et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 36 1 (2000) 326-340
24. Wayhs R., Zelinger A., and Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 39 2 (2002) 225-230
25. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 4 (1990) 827-832
26. Devries S., Wolfkiel C., Shah V., et al. Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. Am J Cardiol 75 14 (1995) 973-975
27. Callister T.Q., Cooil B., Raya S.P., et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 208 3 (1998) 807-814
28. Rybicki F.J., Otero H.J., Steigner M.L., et al. Initial evaluation of coronary images from 320-detector row computed tomography. Int J Cardiovasc Imaging 24 5 (2008) 535-546
29. de Groot E., Jukema J.W., van Boven A.J., et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the regression growth evaluation Statin study. Am J Cardiol 76 9 (1995) 40C-46C
30. Desjardins B., and Kazerooni E.A. ECG-gated cardiac CT. AJR Am J Roentgenol 182 4 (2004) 993-1010
31. Scanlon P.J., Faxon D.P., Audet A.M., et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the society for cardiac angiography and interventions. J Am Coll Cardiol 33 6 (1999) 1756-1824
32. Smith Jr. S.C., Dove J.T., Jacobs A.K., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the society for cardiac angiography and interventions. Circulation 103 24 (2001) 3019-3041
33. Goldstein J.A., Gallagher M.J., O'Neill W.W., et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 49 8 (2007) 863-871
34. Ehara M., Kawai M., Surmely J.F., et al. Diagnostic accuracy of coronary in-stent restenosis using 64-slice computed tomography: comparison with invasive coronary angiography. J Am Coll Cardiol 49 9 (2007) 951-959
35. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 5 (1989) 358-367
36. Dujardin K.S., Enriquez-Sarano M., Rossi A., et al. Echocardiographic assessment of left ventricular remodeling: are left ventricular diameters suitable tools?. J Am Coll Cardiol 30 6 (1997) 1534-1541
37. Helak J.W., and Reichek N. Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation. Circulation 63 6 (1981) 1398-1407
38. Yamaoka O., Yabe T., Okada M., et al. Evaluation of left ventricular mass: comparison of ultrafast computed tomography, magnetic resonance imaging, and contrast left ventriculography. Am Heart J 126 6 (1993) 1372-1379
39. Zaidi H., and Hasegawa B. Determination of the attenuation map in emission tomography. J Nucl Med 44 2 (2003) 291-315
40. Uren N.G., Crake T., Lefroy D.C., et al. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 331 4 (1994) 222-227
41. Yoshinaga K., Katoh C., Noriyasu K., et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol 10 3 (2003) 275-283
42. Thompson R.C., McGhie A.I., Moser K.W., et al. Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging. J Nucl Cardiol 12 4 (2005) 392-400
43. Berman D.S., Wong N.D., Gransar H., et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 44 4 (2004) 923-930
44. Schelbert H.R. 18F-deoxyglucose and the assessment of myocardial viability. Semin Nucl Med 32 1 (2002) 60-69
45. Keng F.Y. Clinical applications of positron emission tomography in cardiology: a review. Ann Acad Med Singap 33 2 (2004) 175-182
46. Alderman E.L., Fisher L.D., Litwin P., et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68 4 (1983) 785-795
47. Emond M., Mock M.B., Davis K.B., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90 6 (1994) 2645-2657
48. Passamani E., Davis K.B., Gillespie M.J., et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 312 26 (1985) 1665-1671
49. Alderman E.L., Corley S.D., Fisher L.D., et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol 22 4 (1993) 1141-1154
50. Mickleborough L.L., Maruyama H., Takagi Y., et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 92 9 Suppl (1995) II73-II79
51. Kaul T.K., Agnihotri A.K., Fields B.L., et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 111 5 (1996) 1001-1012
52. Miller D.C., Stinson E.B., and Alderman E.L. Surgical treatment of ischemic cardiomyopathy; is it ever too late?. Am J Surg 141 6 (1981) 688-693
53. Luciani G.B., Faggian G., Razzolini R., et al. Severe ischemic left ventricular failure: coronary operation or heart transplantation?. Ann Thorac Surg 55 3 (1993) 719-723
54. Ellis S.G., Fisher L., Dushman-Ellis S., et al. Comparison of coronary angioplasty with medical treatment for single- and double-vessel coronary disease with left anterior descending coronary involvement: long-term outcome based on an Emory-CASS registry study. Am Heart J 118 2 (1989) 208-220
55. Shan K., Constantine G., Sivananthan M., et al. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 109 11 (2004) 1328-1334
56. Tillisch J., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314 14 (1986) 884-888
57. Gropler R.J., Geltman E.M., Sampathkumaran K., et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 22 6 (1993) 1587-1597
58. Lucignani G., Paolini G., Landoni C., et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 19 10 (1992) 874-881
59. Tamaki N., Ohtani H., Yamashita K., et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 32 4 (1991) 673-678
60. Marwick T.H., MacIntyre W.J., Lafont A., et al. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation 85 4 (1992) 1347-1353
61. Tamaki N., Yonekura Y., Yamashita K., et al. Prediction of reversible ischemia after coronary artery bypass grafting by positron emission tomography. J Cardiol 21 2 (1991) 193-201
62. Tamaki N., Yonekura Y., Yamashita K., et al. Relation of change in wall motion and glucose metabolism after coronary artery bypass grafting-assessment with positron emission tomography. Jpn Circ J 55 9 (1991) 923-929
63. Tamaki N., Yonekura Y., Yamashita K., et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 64 14 (1989) 860-865
64. Tamaki N., Yonekura Y., Yamashita K., et al. Value of rest-stress myocardial positron tomography using nitrogen-13 ammonia for the preoperative prediction of reversible asynergy. J Nucl Med 30 8 (1989) 1302-1310
65. vom Dahl J., Eitzman D.T., al-Aouar Z.R., et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90 5 (1994) 2356-2366
66. Taegtmeyer H. Myocardial metabolism. In: Phelps M.E., Mazziotta J., and Schelbert H.R. (Eds). Positron emission tomography and autoradiography: principles and applications for the brain and heart (1986), Raven Press, New York 149-195
67. Liedtke A.J. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23 5 (1981) 321-336
68. Liedtke A.J. The origins of myocardial substrate utilization from an evolutionary perspective: the enduring role of glucose in energy metabolism. J Mol Cell Cardiol 29 4 (1997) 1073-1086
69. Liedtke A.J., Renstrom B., Hacker T.A., et al. Effects of moderate repetitive ischemia on myocardial substrate utilization. Am J Phys Am J Phys 269 1 Pt 2 (1995) H246-H253
70. Liedtke A.J., Renstrom B., Nellis S.H., et al. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol 26 3 (1995) 815-825
71. Vanoverschelde J.L., Wijns W., Depre C., et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87 5 (1993) 1513-1523
72. Schelbert H.R., Henze E., Phelps M.E., et al. Assessment of regional myocardial ischemia by positron-emission computed tomography. Am Heart J 103 4 Pt 2 (1982) 588-597
73. Schwaiger M., Fishbein M.C., Block M., et al. Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: noninvasive assessment by positron emission tomography. J Mol Cell Cardiol 19 3 (1987) 259-269
74. Kalff V., Schwaiger M., Nguyen N., et al. The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose. J Nucl Med 33 7 (1992) 1346-1353
75. Knuuti M.J., Yki-Jarvinen H., Voipio-Pulkki L.M., et al. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 35 6 (1994) 989-998
76. Kam B.L., Valkema R., Poldermans D., et al. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration. J Nucl Med 44 2 (2003) 140-145
77. Bax J.J., Veening M.A., Visser F.C., et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 24 1 (1997) 35-41
78. Martin W.H., Jones R.C., Delbeke D., et al. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography. Eur J Nucl Med 24 10 (1997) 1291-1297
79. Knuuti M.J., Saraste M., Nuutila P., et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 127 4 Pt 1 (1994) 785-796
80. Schoder H., Campisi R., Ohtake T., et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 33 5 (1999) 1328-1337
81. Baer F.M., Voth E., Deutsch H.J., et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 28 1 (1996) 60-69
82. Bax J.J., Cornel J.H., Visser F.C., et al. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization. J Nucl Cardiol 4 4 (1997) 302-308
83. Marwick T.H., Nemec J.J., Lafont A., et al. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 69 9 (1992) 854-859
84. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92 12 (1995) 3436-3444
85. Pagano D., Townend J.N., Littler W.A., et al. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 115 4 (1998) 791-799
86. Landoni C., Lucignani G., Paolini G., et al. Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability. J Cardiovasc Surg (Torino) 40 3 (1999) 363-372
87. Haas F., Haehnel C.J., Picker W., et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30 7 (1997) 1693-1700
88. Beanlands R.S., Hendry P.J., Masters R.G., et al. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98 19 Suppl (1998) II51-II56
89. Eitzman D., al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20 3 (1992) 559-565
90. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 90 6 (1994) 2687-2694
91. Di Carli M.F., Maddahi J., Rokhsar S., et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 116 6 (1998) 997-1004
92. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 7 (2002) 1151-1158
93. Woodard P.K., Bhalla S., Javidan-Nejad C., et al. Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults. Curr Treat Options Cardiovasc Med 10 5 (2008) 419-424
94. Koskenvuo J.W., Karra H., Lehtinen J., et al. Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences. Clin Physiol Funct Imaging 27 6 (2007) 385-393
95. Lotz J., Meier C., Leppert A., et al. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics 22 3 (2002) 651-671
96. Desai M.Y., Lai S., Barmet C., et al. Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J 26 21 (2005) 2320-2324
97. Dellegrottaglie S., and Fayad Z.A. Does the combination of stress perfusion and delayed-enhancement MRI improve the detection of CAD?. Nat Clin Pract Cardiovasc Med 3 9 (2006) 472-473
98. Jakob P.M., and Haase A. Basic pulse sequences for fast cardiac MR imaging. MAGMA 6 2-3 (1998) 84-87
99. Chrysikopoulos H.S. Clinical MR imaging and physics: a tutorial (2009), Springer-Verlag, Berlin
100. Swaminathan S., Horn T.D., Pellowski D., et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med 357 7 (2007) 720-722
101. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 9 (2006) 2359-2362
102. Nguyen T.D., Spincemaille P., Cham M.D., et al. Free-breathing 3D steady-state free precession coronary magnetic resonance angiography: comparison of diaphragm and cardiac fat navigators. J Magn Reson Imaging 28 2 (2008) 509-514
103. Doesch C., Seeger A., Hoevelborn T., et al. Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease. Clin Res Cardiol 97 12 (2008) 905-912
104. Jerosch-Herold M., and Kwong R.Y. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease. Curr Opin Cardiol 23 6 (2008) 599-606
105. Ripa R.S., Nilsson J.C., Wang Y., et al. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. Am Heart J 154 5 (2007) 929-936
106. Bohl S., Wassmuth R., Abdel-Aty H., et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 24 6 (2008) 597-607
107. Jackson E., Bellenger N., Seddon M., et al. Ischaemic and non-ischaemic cardiomyopathies-cardiac MRI appearances with delayed enhancement. Clin Radiol 62 5 (2007) 395-403
108. Hansen M.W., and Merchant N. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol 189 6 (2007) 1335-1343
109. Francone M., Dymarkowski S., Kalantzi M., et al. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 16 4 (2006) 944-951
110. Chinnaiyan K.M., Leff C.B., and Marsalese D.L. Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis and management. Cardiol Rev 12 6 (2004) 314-320
111. Syed I.S., Feng D., Harris S.R., et al. MR imaging of cardiac masses. Magn Reson Imaging Clin N Am 16 2 (2008) 137-164 vii
112. Saha G.B. Basics of PET imaging: physics, chemistry, and regulations. 1st edition (2004), Springer Science+Business Media, Inc, New York
113. Christensen N.L., Hammer B.E., Heil B.G., et al. Positron emission tomography within a magnetic field using photomultiplier tubes and lightguides. Phys Med Biol 40 4 (1995) 691-697
114. Slates R.B., Farahani K., Shao Y., et al. A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. Phys Med Biol 44 8 (1999) 2015-2027
115. Woods R.P., Mazziotta J.C., and Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17 4 (1993) 536-546
116. Knuesel P.R., Nanz D., Wyss C., et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108 9 (2003) 1095-1100
117. Bengel F.M., Ueberfuhr P., Schiepel N., et al. Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography. Circulation 103 14 (2001) 1881-1886
118. Glass C.K., and Witztum J.L. Atherosclerosis. the road ahead. Cell 104 4 (2001) 503-516
119. Virmani R., Burke A.P., Farb A., et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 8 Suppl (2006) C13-C18
120. Robbie L., and Libby P. Inflammation and atherothrombosis. Ann N Y Acad Sci 947 (2001) 167-179 discussion 79-80
121. Libby P. Inflammation in atherosclerosis. Nature 420 6917 (2002) 868-874
122. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12 1 (1988) 56-62
123. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 78 5 Pt 1 (1988) 1157-1166
124. Myerburg R.J. Sudden cardiac death in persons with normal (or near normal) hearts. Am J Cardiol 79 6A (1997) 3-9
125. Fuster V., Badimon L., Badimon J.J., et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 5 (1992) 310-318
126. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 32 3 (1998) 655-662
127. Ogawa M., Ishino S., Mukai T., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45 7 (2004) 1245-1250
128. Tawakol A., Migrino R.Q., Hoffmann U., et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12 3 (2005) 294-301
129. Lederman R.J., Raylman R.R., Fisher S.J., et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 22 7 (2001) 747-753
130. Tahara N., Kai H., Nakaura H., et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 28 18 (2007) 2243-2248
131. Rudd J.H., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 23 (2002) 2708-2711
132. Tawakol A., Migrino R.Q., Bashian G.G., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 9 (2006) 1818-1824
133. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 9 (2006) 1825-1831
134. Crisby M., Nordin-Fredriksson G., Shah P.K., et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 7 (2001) 926-933
135. Corti R., Fayad Z.A., Fuster V., et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104 3 (2001) 249-252
136. Ogawa M., Magata Y., Kato T., et al. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med 47 11 (2006) 1845-1850
137. Theron J., and Tyler J.L. Takayasu's arteritis of the aortic arch: endovascular treatment and correlation with positron emission tomography. AJNR Am J Neuroradiol 8 4 (1987) 621-626
138. Mochizuki Y., Fujii H., Yasuda S., et al. FDG accumulation in aortic walls. Clin Nucl Med 26 1 (2001) 68-69
139. Yun M., Yeh D., Araujo L.I., et al. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 4 (2001) 314-319
140. Yun M., Jang S., Cucchiara A., et al. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32 1 (2002) 70-76
141. Tatsumi M., Cohade C., Nakamoto Y., et al. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 229 3 (2003) 831-837
142. Ben-Haim S., Kupzov E., Tamir A., et al. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45 11 (2004) 1816-1821
143. Bural G.G., Torigian D.A., Chamroonrat W., et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35 3 (2008) 562-569
144. Basu S., Zhuang H., and Alavi A. Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates. Clin Nucl Med 32 7 (2007) 567-568
145. Dunphy M.P., Freiman A., Larson S.M., et al. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46 8 (2005) 1278-1284
146. Ben-Haim S., Kupzov E., Tamir A., et al. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol 13 6 (2006) 791-800
147. Weissberg P.L. Noninvasive imaging of atherosclerosis: the biology behind the pictures. J Nucl Med 45 11 (2004) 1794-1795
148. Davies J.R., Rudd J.H., Fryer T.D., et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36 12 (2005) 2642-2647
149. Arauz A., Hoyos L., Zenteno M., et al. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 109 5 (2007) 409-412
150. Paulmier B., Duet M., Khayat R., et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 15 2 (2008) 209-217
151. Bural G.G., Torigian D.A., Chamroonrat W., et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl Med Biol 33 8 (2006) 1037-1043
152. Rudd J.H., Myers K.S., Bansilal S., et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 49 6 (2008) 871-878
153. Langer O., and Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imaging 29 3 (2002) 416-434
154. Law M.P., Osman S., Pike V.W., et al. Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography. Eur J Nucl Med 27 1 (2000) 7-17
155. Delforge J., Le Guludec D., Syrota A., et al. Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med 34 6 (1993) 981-991
156. Delforge J., Janier M., Syrota A., et al. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation 82 4 (1990) 1494-1504
157. Wu J.C., Inubushi M., Sundaresan G., et al. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106 2 (2002) 180-183
158. Inubushi M., Wu J.C., Gambhir S.S., et al. Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation 107 2 (2003) 326-332